RANBAXY

Press Statement Issued by Ranbaxy Laboratories Limited

GURGAON, India, Feb. 25 /PRNewswire/ -- Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from Ranbaxy's Paonta Sahib facility have been added to a list maintained under a policy entitled "Application Integrity Policy" or "AIP". Ranbaxy will analyze...

Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN

Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Aug. 6 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that it has entered into a definitive development, distribution and supply agreement with Ranbaxy Pharmaceuticals Inc. ("RPI"...

Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr

Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy Laboratories on a preferential basis for Rs 20 crore. // The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shar...

Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu

New Delhi: SRL Ranbaxy has introduced a diagnostic test for Bird Flu that will enable mass-screening, and has the capability to report near accurate results within 24 hours. Named as RT-PCR test, // this test boasts of being powerful where the results will be available in a day. Certainly a blessin...

SRL Ranbaxy offers quicker bird flu diagnostic test

SRL Ranbaxy, a pathology laboratory network promoted by India's pharma major Ranbaxy Laboratories, Monday announced the launch of the first diagnostic// test for bird flu that can give results in just a day. "A first of its kind, it is the only diagnostic test for bird flu that can be effectivel...

Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA

Ranbaxy Laboratories (RL) has received its first tentative approval from the US Food and drug administration ( FDA ) to manufacture // and market lamivudine tablets that can be used in combination with other anti - retroviral agents (ARVs) to treat patients with HIV infection. The approval ha...

New FDLI Book Maps Out Pharmacovigilance Provisions in More Than a Dozen Countries

...arthritis. The contaminated heparin caused dozens of deaths and hundreds of injuries. In February 2009, the Food and Drug Administration accused ranbaxy Pharmaceuticals, an Indian manufacturer of generic drugs, of falsifying data used to obtain regulatory approval for U.S. distribution. These deve...

Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets

... PRINCETON, N.J., March 5 /PRNewswire/ -- ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of ranbaxy Laboratories Limited (RLL), announced today that R.... Food and Drug Administration, has determined the ranbaxy formulations to be bioequivalent and have the same...

FDA Halts New Applications From Indian Drug Maker's Plant

... Agency says ranbaxy Laboratories facility falsified scientific data ...ted the review of any new drug applications from a ranbaxy Laboratories plant in India after determining the ... Sahib facility in less than six months. "No other ranbaxy facilities are directly affected by this action," ...

Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide

... ranbaxy Will Market Generic Atorvastatin in the U.S. With ... $12.7 billion. The agreement pertains solely to ranbaxy and its affiliates and does not cover legal challe...involving other generic manufacturers. However, as ranbaxy was the first generic challenger to the listed Lip...

More>>

RANBAXY in Medical Technology

Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding

...y signed license agreements for the sales and marketing of Sanvar(R), with several commercial partners that include Salix Pharmaceuticals in the U.S., ranbaxy Laboratories Ltd in India, EMS Sigma Farma in Brasil, LG Life Sciences in Korea, Tzamal Bio-Pharma Ltd in Israel, and Medical Futures in Canada. Abo...

Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP

... PRINCETON, N.J., Aug. 20 /PRNewswire/ -- ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of ranbaxy Laboratories Limited (RLL), announced today that R.... Food and Drug Administration, has determined the ranbaxy formulations to be bioequivalent and have the same...

RANBAXY in Biological News

SCI marks expansion into Asia with the launch of SCI INDIA

...ju Shroff, Chairman & Managing Director of United Phosphorus Limited, Dr. Ian Cliffe, Director-Head, Medicinal Chemistry, New Drug Discovery Research, ranbaxy Laboratories Limited, Mr. Raj Kapur, Regional Manager South Asia, Managing Director India, Dow Corning India Pvt. Ltd, Mr . Pradip Dave, Chairman & ...

RANBAXY in Biological Technology

Daiichi Sankyo and Ranbaxy Confirm Deal Is Binding and Final, Allay Market Rumour and Speculation

TOKYO, and NEW DELHI, India, July 17 /PRNewswire/ -- Following intense speculation in sections of the media and the stock market, Daiichi Sankyo Company, Limited (TSE: 4568.JP) ("Daiichi Sankyo") and Ranbaxy Laboratories Limited (NSE/BSE: Ranbaxy/500359) ("Ranbaxy") reiterate that the agreemen...

Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case

TOKYO and RIDGEFIELD, Conn., Nov. 8 /PRNewswire/ -- Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc. (a subsidiary of Boehringer Ingelheim Corporation) announced today that the two companies have reached a settlement agreement with Ranbaxy to enter into a stipulation of dism...

Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules in the U.S.

... PRINCETON, N.J., May 1 /PRNewswire/ -- ranbaxy Pharmaceuticals Inc. (RPI) announced today that it...rmity with the approved laboratory specifications, ranbaxy decided to recall all the lots, as a matter of abu... commitment to the health and safety of patients. ranbaxy is continuing to look into the cause of such non-c...

Ranbaxy Launches Omeprazole 40 mg Capsules

...s of trade in the U.S. healthcare system under the ranbaxy label," said Jim Meehan, Vice President of Sales a...mulation to patients requiring this medication." ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of ranbaxy Laboratories Limited (RLL), India's largest pharma...

Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets

...pproval PRINCETON, N.J., June 25 /PRNewswire/ -- ranbaxy Laboratories Limited (RLL), announced today that t...blets were $239 million (IMS - MAT: March 2008). ranbaxy believes that it has First-to-File status on Valga...alue and utility over time. It will be launched by ranbaxy upon receiving final approval and resolution of li...

Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit

... key member of the team that established collaboration agreements between Merck and leading pharmaceutical firms in India such as Nicholas Piramal and ranbaxy Labs. Dr. Chowrira also served as Vice President of Sirna Therapeutics, a wholly owned subsidiary of Merck, where his responsibilities included strate...

Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

...prazole magnesium. Under the settlement agreement, ranbaxy concedes that all six patents asserted by AstraZen...enforceable. The settlement agreement will allow ranbaxy to commence exclusive sales of a generic version o...Esomeprazole magnesium product in the US market. ranbaxy has filed a Consent Judgment with the U.S. Distric...

Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules

... PRINCETON, N.J., Feb. 7 /PRNewswire/ -- ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of ranbaxy Laboratories Limited (RLL), announced today that R...les of $5.5 billion (IMS -- MAT: December 2007). ranbaxy believes that it has a FTF (First to File) status ...

Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement

...(R) product. The defendants named in the lawsuit include Dr. Reddy's Laboratories Limited, Genpharm Inc., Interpharm Inc., Mylan Pharmaceuticals Inc., ranbaxy Laboratories Limited, Sun India Pharmaceutical Industries Limited, and related companies and subsidiaries thereof. The '703 patent expires in April 20...

Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology

...es to 45% GURGAON, India, Oct. 3 /PRNewswire/ -- ranbaxy Laboratories Limited (Ranbaxy) and Zenotech Labora...ents, providing for an increase in equity stake by ranbaxy from its current 7% to 45% at a price of Rs. 160 p... the existing Promoters (b) Preferential Offer to ranbaxy by Zenotech The above triggers a mandatory open o...